- Home
- TTD vs NBIX Comparison
TTD vs NBIX Comparison
Compare TTD & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TTD | NBIX |
|---|---|---|
| Founded | 2009 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.9B | 15.2B |
| IPO Year | 2016 | 1996 |
Fundamental Metrics
Financial Performance| Metric | TTD | NBIX |
|---|---|---|
| Price | $38.33 | $145.25 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 35 | 21 |
| Target Price | $80.85 | ★ $176.19 |
| AVG Volume (30 Days) | ★ 13.8M | 942.0K |
| Earning Date | 02-11-2026 | 02-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 42.00 | 12.44 |
| EPS | 0.88 | ★ 4.19 |
| Revenue | ★ $2,790,505,000.00 | $2,682,700,000.00 |
| Revenue This Year | $19.44 | $23.68 |
| Revenue Next Year | $16.13 | $18.47 |
| P/E Ratio | $43.51 | ★ $34.65 |
| Revenue Growth | ★ 20.82 | 19.61 |
| 52 Week Low | $35.65 | $84.23 |
| 52 Week High | $127.59 | $160.18 |
Technical Indicators
Market Signals| Indicator | TTD | NBIX |
|---|---|---|
| Relative Strength Index (RSI) | 43.27 | 44.40 |
| Support Level | $36.79 | $141.00 |
| Resistance Level | $38.00 | $148.56 |
| Average True Range (ATR) | 1.05 | 4.27 |
| MACD | 0.41 | -0.94 |
| Stochastic Oscillator | 57.87 | 20.49 |
Price Performance
Historical ComparisonAbout TTD The Trade Desk Inc.
The Trade Desk provides a self-service platform that helps advertisers and ad agencies programmatically find and purchase digital ad inventory (display, video, audio, and social) on devices like computers, smartphones, and connected TVs. It uses data in an iterative manner to optimize the performance of ad impressions purchased. The firm's platform is referred to as a demand-side platform in the digital ad industry, and it generates revenue from fees based on a percentage of what its clients spend on advertising.
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.